Mocumbi A, Humbert M, Saxena A, Jing ZC, Sliwa K, Thienemann F, Archer SL, Stewart S. Pulmonary hypertension. Nat Rev Dis Prim. 2024;10(1):1. https://doi.org/10.1038/s41572-023-00486-7.

Article  PubMed  Google Scholar 

Hansmann G. Pulmonary hypertension in infants, children, and young adults. J Am Coll Cardiol. 2017;69(20):2551–69. https://doi.org/10.1016/j.jacc.2017.03.575.

Article  PubMed  Google Scholar 

Dodson MW, Brown LM, Elliott CG. Pulmonary arterial hypertension. Heart Fail Clin. 2018;14(3):255–69. https://doi.org/10.1016/j.hfc.2018.02.003.

Article  PubMed  Google Scholar 

Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37(12):942–54. https://doi.org/10.1093/eurheartj/ehv512.

Article  PubMed  Google Scholar 

Brusca SB, Zou Y, Elinoff JM. How low should we go? Potential benefits and ramifications of the pulmonary hypertension hemodynamic definitions proposed by the 6th World Symposium. Curr Opin Pulm Med. 2020;26(5):384–90. https://doi.org/10.1097/MCP.0000000000000699.

Article  PubMed  PubMed Central  Google Scholar 

Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA, et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med. 2001;345(5):319–24. https://doi.org/10.1056/nejm200108023450502.

Article  CAS  PubMed  Google Scholar 

Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais M-C, et al. Sex and gender in pulmonary arterial hypertension. Eur Respir Rev. 2021. https://doi.org/10.1183/16000617.0330-2020.

Article  PubMed  PubMed Central  Google Scholar 

Montani D, Girerd B, Jais X, Laveneziana P, Lau EMT, Bouchachi A, et al. Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation. Eur Respir J. 2021. https://doi.org/10.1183/13993003.04229-2020.

Article  PubMed  PubMed Central  Google Scholar 

McGoon MD, Miller DP. Reveal: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21(123):8–18. https://doi.org/10.1183/09059180.00008211.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taraseviciute A, Voelkel NF. Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res. 2006;11(5):198–202.

PubMed  Google Scholar 

Honigberg MC, Patel AP, Lahm T, Wood MJ, Ho JE, Kohli P, et al. Association of premature menopause with incident pulmonary hypertension: a cohort study. PLoS ONE. 2021. https://doi.org/10.1371/journal.pone.0247398.

Article  PubMed  PubMed Central  Google Scholar 

Dubey RK, Jackson EK. Genome and hormones: gender differences in physiology: invited review: cardiovascular protective effects of 17β-estradiol metabolites. J Appl Physiol. 2001;91(4):1868–83. https://doi.org/10.1152/jappl.2001.91.4.1868.

Article  CAS  PubMed  Google Scholar 

Baird GL, Archer-Chicko C, Barr RG, Bluemke DA, Foderaro AE, Fritz JS, et al. Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension. Eur Respir J. 2018. https://doi.org/10.1183/13993003.00467-2018.

Article  PubMed  PubMed Central  Google Scholar 

Abdulkareem AO, Tiwari P, Lone ZR, Iqbal H, Gupta S, Jha RK, et al. Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension. Eur J Pharmacol. 2023;943:175558. https://doi.org/10.1016/j.ejphar.2023.175558.

Article  CAS  PubMed  Google Scholar 

Frump AL, Albrecht M, Yakubov B, Breuils-Bonnet S, Nadeau V, Tremblay E, et al. 17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin. J Clin Invest. 2021. https://doi.org/10.1172/jci129433.

Article  PubMed  PubMed Central  Google Scholar 

Tofovic SP, Jones T, Petrusevska G. Dose-dependent therapeutic effects of 2-methoxyestradiol on monocrotaline-induced pulmonary hypertension and vascular remodelling. Prilozi. 2010;31(1):279–95.

CAS  PubMed  Google Scholar 

Ritter JK, Sheen YY, Owens IS. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells: 3,4-catechol estrogens and estriol as primary substrates. J Biol Chem. 1990;265(14):7900–6.

Article  CAS  PubMed  Google Scholar 

Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther. 1993;57(2–3):237–57. https://doi.org/10.1016/0163-7258(93)90057-k.

Article  CAS  PubMed  Google Scholar 

Hernandez JS, Watson RW, Wood TC, Weinshilboum RM. Sulfation of estrone and 17 beta-estradiol in human liver: catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase. Drug Metab Dispos. 1992;20(3):413–22.

CAS  PubMed  Google Scholar 

Fishman J. Aromatic hydroxylation of estrogens. Annu Rev Physiol. 1983;45:61–72. https://doi.org/10.1146/annurev.ph.45.030183.000425.

Article  CAS  PubMed  Google Scholar 

Lee AJ, Mills LH, Kosh JW, Conney AH, Zhu BT. NADPH-dependent metabolism of estrone by human liver microsomes. J Pharmacol Exp Ther. 2002;300(3):838–49. https://doi.org/10.1124/jpet.300.3.838.

Article  CAS  PubMed  Google Scholar 

Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, et al. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev. 2006;15(3):551–8. https://doi.org/10.1158/1055-9965.Epi-05-0801.

Article  CAS  PubMed  Google Scholar 

Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl. 1980;232:1–127.

CAS  Google Scholar 

Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51(4):593–628.

CAS  PubMed  Google Scholar 

Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 1998;58(11):2269–77.

CAS  PubMed  Google Scholar 

Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Toxicology. 2004;204(2–3):197–202. https://doi.org/10.1016/j.tox.2004.06.026.

Article  CAS  PubMed  Google Scholar 

Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem. 1993;268(17):12964–9.

Article  CAS  PubMed  Google Scholar 

Chapman E, Best MD, Hanson SR, Wong CH. Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl. 2004;43(27):3526–48. https://doi.org/10.1002/anie.200300631.

Article  CAS  PubMed  Google Scholar 

Strott CA. Steroid sulfotransferases. Endocr Rev. 1996;17(6):670–97. https://doi.org/10.1210/er.17.6.670.

Article  CAS  PubMed  Google Scholar 

Hobkirk R. Steroid sulfation current concepts. Trends Endocrinol Metab. 1993;4(2):69–74. https://doi.org/10.1016/s1043-2760(05)80018-9.

Article  CAS  PubMed